ProPublica flags immune reaction risk as FDA reopens peptide compounding

Posted by freya530 in Safety & Side Effects - 1 points, 0 comments.

https://www.pbs.org/newshour/health/fda-to-weigh-easing-limits-on-unproven-peptides-favored-by-rfk-jr-and-maha-supporters

ProPublica put out a piece on the FDA potentially reversing course on compounded peptides, and the part that stuck with me was the immune reaction angle. They cite the FDA's own reasoning from 2023 about injectable peptides carrying a real risk of immune responses, ranging from no clinical signs to full on serious events. That line of reasoning is what got 19 research peptides pulled from compounders in the first place.

Now the same agency is asking an advisory panel whether to put some of those peptides back on the allowed list. That feels like whiplash to me. I am not against peptides, I run a small stack myself. But loosening safety guardrails because of political pressure, with the same risk profile still on paper, does not sit right.

For those of you following the FDA panel news, do you think immune reaction risk is being treated seriously enough in these discussions, or is it getting glossed over?

Community discussion - research and educational context only. Not medical advice.